博士論文

Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Digital data available

Find on the publisher's website

国立国会図書館デジタルコレクション

Digital data available

Check on the publisher's website

DOI[10.1007/s00535-018-01541-x]to the data of the same series

Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice

Persistent ID (NDL)
info:ndljp/pid/12317374
Material type
博士論文
Author
土居, 哲
Publisher
土居, 哲
Publication date
2020
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
大阪大学,博士(医学)
View All

Notes on use at the National Diet Library

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice
Author/Editor
土居, 哲
Publication, Distribution, etc.
土居, 哲
Publication Date
2020
Publication Date (W3CDTF)
2020
Alternative Title
ヒト肝細胞キメラマウスにおいて、NS3/4A阻害薬、NS5B阻害薬ならびに非選択的抗ウイルス薬のうち2剤以上を併用した治療法は、NS5A P32欠失変異を有するC型肝炎ウイルスに対して有効である
Degree grantor/type
大阪大学
Date Granted
2020-03-25
Date Granted (W3CDTF)
2020-03-25